Relevance of health economics in breast cancer treatment: integration of economics in the management of breast cancer at the clinic level.
Since the introduction of the diagnosis-related groups (DRG) system with cost-related and entity-specific flat-rate reimbursements for all in-patients in 2004 in Germany, economics have become an important focus in medical care, including breast centers. Since then, physicians and hospitals have had to gradually take on more and more financial responsibilities for their medical care to avoid losses for their institutions. Due to financial limitations of resources, most medical services have to be adjusted to correlating revenues, which results in the development of a variety of active measures to understand, steer, and optimize costs, resources and related processes for breast cancer treatment. In this review, the challenging task to implement microeconomic management at the clinic level for breast cancer treatment is analyzed from breast cancer-specific publications. The newly developed economic management perspective is identified for different stakeholders in the healthcare system, and successful microeconomic projects and future aspects are described.
Frauenklinik (OB/GYN) of Salzburger Landeskrankenanstalten (SALK) and Paracelsus Medical University (PMU), Salzburg, Austria.
Volker R
VR
Jacobs
Frauenklinik (OB/GYN) of Salzburger Landeskrankenanstalten (SALK) and Paracelsus Medical University (PMU), Salzburg, Austria.
Gerhard
G
Bogner
Frauenklinik (OB/GYN) of Salzburger Landeskrankenanstalten (SALK) and Paracelsus Medical University (PMU), Salzburg, Austria.
Christiane E
CE
Schausberger
Frauenklinik (OB/GYN) of Salzburger Landeskrankenanstalten (SALK) and Paracelsus Medical University (PMU), Salzburg, Austria.
Roland
R
Reitsamer
Frauenklinik (OB/GYN) of Salzburger Landeskrankenanstalten (SALK) and Paracelsus Medical University (PMU), Salzburg, Austria.
Thorsten
T
Fischer
Breast cancer; Costs of treatment; Health economics; Limited resources; Microeconomic solutions